Medication safety in older adults in India: an integrative PhD synthesis of direct evidence and contextual implementation evidence.

Glob Health ActionAug 17, 2026 (epub)
Clinical ResearchGeriatricsOpen access

Saibal Das

✦ AI-curated · Sources linked

In 30 seconds

This systematic review synthesizes evidence on medication safety among older adults in India, highlighting issues like polypharmacy and inappropriate prescribing. The study found that one-third of older adults experienced polypharmacy, with risks heightened by multimorbidity and care transitions. Deprescribing did not significantly increase adverse outcomes, but evidence quality was low.

Key findings

  • One-third of older adults in a multicity study had polypharmacy.
  • Polypharmacy was linked to higher anticholinergic burden and cardiac autonomic neuropathy.
  • Deprescribing showed no significant increase in mortality or hospitalization.
  • Informal-provider interventions may enhance medication-related practices.

Why it matters

Understanding medication safety in older adults is crucial for improving health outcomes, particularly in low- and middle-income countries where complex health needs and care systems can lead to unsafe practices.

Source

Published in Glob Health Action. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Geriatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.